Higlance Laboratories - Due diligence report

A 360° intelligence report on Higlance Laboratories: trust score, financial health, credit view, compliance, directors, growth and distress …

2003-06-11 New Delhi, Delhi Active Unlisted Active Compliant
Share
Connect MCP
HL Higlance Laboratories
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Higlance Laboratories — 360° Intelligence Report

Generated from MCA filings & public records
75/100
Trust Score
Low Risk

Higlance Laboratories is assessed as Low Risk with a Trust Score of 75/100. Higlance Laboratories is an active private limited indian non-government company incorporated in 2003, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 02 Oct 2026 from the latest processed filings. Higlance Laboratories Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
57/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (1.86 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India1 48.0 cr
Compliance Score: 57/100 Moderate
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2024 - filings overdue.
  • 2 auditor resignation(s) filed - latest: NAVEEN JAIN & CO on 2015-09-07.
  • Delayed payments to MSME suppliers disclosed (2 disclosure(s)).
  • 3 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
KALAWATI DEVI 01234567 Director 01/04/2018 6 yrs Approved
AJAY SINGH 01234567 Director 01/04/2018 6 yrs Approved
SANJAY KUMAR SINGH 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: AJAY SINGH (Whole-time director) · SANJAY KUMAR SINGH (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 23+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Statutory filings appear overdue.
Compliance score is weak (57/100).
1 open charge(s) registered - assets are encumbered.
2 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 5.54 Lakh.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence65/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 1.86 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view77/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2024
Last AGM held
Annual general meeting
31 May 2024
Director ceased
ANISHRAVA AGRAWAL
31 Mar 2024
Latest balance sheet
Filed with ROC
10 Mar 2018
Director ceased
AJAY SINGH
Director ceased
SANJAY KUMAR SINGH
31 Aug 2011
Director ceased
DINESH GUPTA
30 Mar 2011
Securities allotted
1000000.00 Equity Shares - 3.00 cr raised
19 Oct 2006
Charge created
State Bank Of India - 1.86 cr
11 Jun 2003
Incorporated
Registered with Roc Delhi
Director appointed
KALAWATI DEVI (Director)
Director appointed
AJAY SINGH (Whole-time director)
Director appointed
SANJAY KUMAR SINGH (Managing Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Jsw Industrial Gases U85110MH1995PLC293892 Mumbai, Maharashtra, India
Himachal Polyolefins Limited U24114HP1994PLC014726 Sirmaur, Himachal Pradesh, India
Androst Biotech India Private Limited U24100GJ2022PTC133647 Anand, Gujarat, India
Yash Pharma Laboratories Private Limited U24239MH1972PLC300611 Thane, Maharashtra, India
Bochem Healthcare Private Limited U33114MP1999PTC013855 Ujjain, Madhya Pradesh, India
Oscar Remedies U24230HR1990PTC031079 Haryana, Haryana, India
Gsk U24230PN1997PTC222142 Bhor, Maharashtra, India
Hema Pharmaceuticals Pvt Ltd U24230GJ1988PTC010557 Ankleshwar, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Higlance Laboratories before audits and certifications: compliance score 57/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Higlance Laboratories: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Higlance Laboratories - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Higlance Laboratories pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Higlance Laboratories - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Higlance Laboratories an active company?

Higlance Laboratories has MCA status “Active” with a compliance score of 57/100 (Moderate).

Is Higlance Laboratories financially healthy?

Higlance Laboratories has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Higlance Laboratories?

Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Higlance Laboratories?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Higlance Laboratories have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Higlance Laboratories up to date with its ROC filings?

Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 57/100 (Moderate).

Is it risky to lend to Higlance Laboratories?

Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.